Solara Active Pharma Sciences Ltd.
BSE: 541540 | Sector: Health care |
NSE: SOLARA | ISIN Code: INE624Z01016 |
BSE 09:58 | 21 Mar | 363.70 |
0.55 (0.15%) |
OPEN
368.10 |
HIGH
368.10 |
LOW
360.65 |
NSE 09:44 | 21 Mar | 363.60 |
0.50 (0.14%) |
OPEN
365.15 |
HIGH
366.05 |
LOW
360.40 |
OPEN | 368.10 |
PREVIOUS CLOSE | 363.15 |
VOLUME | 6785 |
52-Week high | 838.35 |
52-Week low | 323.65 |
P/E | |
Mkt Cap.(Rs cr) | 1,309 |
Buy Price | 364.15 |
Buy Qty | 3.00 |
Sell Price | 365.00 |
Sell Qty | 100.00 |
Solara Active Pharma Sciences Ltd. (SOLARA) - Net Profit
Net Profit
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
Cipla | 871.55 | 4.30 | 0.50 | 2957.93 |
Divi's Lab. | 2793.00 | -5.95 | -0.21 | 2948.54 |
Glenmark Pharma. | 440.90 | -4.10 | -0.92 | 1997.79 |
Glaxosmi. Pharma | 1290.00 | 8.25 | 0.64 | 1690.53 |
Dr Reddy's Labs | 4472.40 | 30.60 | 0.69 | 1623.20 |
Alkem Lab | 3137.10 | 28.45 | 0.92 | 1541.25 |
Aurobindo Pharma | 473.50 | -0.75 | -0.16 | 1454.71 |
Gland Pharma | 1190.00 | 26.20 | 2.25 | 1212.16 |
Torrent Pharma. | 1515.75 | -6.35 | -0.42 | 991.45 |
Sanofi India | 5737.40 | 21.40 | 0.37 | 944.40 |
Ipca Labs. | 782.45 | 1.60 | 0.20 | 870.94 |
Zydus Lifesci. | 474.55 | -1.30 | -0.27 | 857.90 |
Abbott India | 21210.00 | -94.00 | -0.44 | 798.70 |
Laurus Labs | 303.10 | 0.70 | 0.23 | 750.09 |
Ajanta Pharma | 1200.00 | 16.95 | 1.43 | 719.86 |
Apollo Hospitals | 4328.00 | 22.55 | 0.52 | 665.20 |
Pfizer | 3538.55 | 5.55 | 0.16 | 612.56 |
Suven Pharma | 471.15 | -0.75 | -0.16 | 558.10 |
Alembic Pharma | 480.60 | 1.35 | 0.28 | 543.55 |
Glenmark Life | 413.85 | 3.70 | 0.90 | 418.72 |
Quick Links for Solara Active Pharma Sciences:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices